Research Article: Evaluation of the efficacy and safety of immunotherapy in sarcoma: a two-center study
Abstract:
Background: Sarcoma is a highly heterogeneous malignancy with a poor prognosis. Although chemotherapy and targeted therapy have improved the prognosis to some extent, the efficacy remains unsatisfactory in some patients. The efficacy and safety of immunotherapy in sarcoma need further evaluation.
No summary available.